The content on this site is intended for healthcare professionals only
James N'Dow talks to ecancer at EAPM 2017 in Belfast.
He talks about the role of guidelines in personalised medicine, and how these are not always effectively implemented.
He encourages that before we push the boundaries too much, we should ensure that our current knowledge is implemented in the most effective way possible.
He ends by explaining how positive the benefits could be if we implemented personalised medicine guidelines effectively.
Innovating cancer care access for low and middle-income countries
Prostate cancer
Synthetic biology and precision medicine in blood and gynaecological cancers
Introducing oncology to undergraduate medical and allied health sciences students
OncoAlert Round Up for September 15-21, 2023
Choosing Wisely in pathology
Choosing Wisely in radiology Tanzania
The use of IORT at Universitätsmedizin Mannheim hospital
Combination of camonsertib plus PARPi shows clinical activity in DDR-aberrant tumours
